Oncogene - Table of Contents alert Volume 35 Issue 15

If you are unable to see the message below, click here to view.

Advertisement The newest ChIP-grade antibodies  Diagenode focuses exclusively on epigenetics and provides the largest selection of validated antibodies with dedicated technical expertise and support. Our antibodies are the only ones on the market that are validated in-house for ChIP-seq. Check out our newest antibodies. TABLE OF CONTENTS Volume 35, Issue 15 (April 2016) In this issue Review Original Articles Short Communications Also new AOP Advertisement ATTENDING AACR? MURPHY'S LAB WILL BE THERE! Everyone gets frustrated in the workplace, and we want to hear your gripes. Tell us what bothers you, and it might be featured in our next illustration. Stop by booth #2012 to pick up FREE Murphy's Lab merchandise. Date: Sunday, 17th April, 2016 Time: 1pm until supplies last Location: Nature booth #2012 LEARN MORE Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Don't miss the latest focus issues from Laboratory Investigation and Modern Pathology Focus on Breast Highlighting recent advances in breast cancer diagnosis and treatment. Focus on Soft Tissue Advancing understanding of the pathogenesis of soft tissue sarcomas, and describing advances that may lead to the development of new diagnostic tests and targeted therapies. Review Top Targeting BCL-2 to enhance vulnerability to therapy in estrogen receptor-positive breast cancer D Merino, S W Lok, J E Visvader and G J Lindeman Oncogene 2016 35: 1877-1887; advance online publication, August 10, 2015; 10.1038/onc.2015.287 Abstract | Full Text Original Articles Top Regulation of complement-dependent cytotoxicity by TGF-β-induced epithelial–mesenchymal transition M T Goswami, A K Reka, H Kurapati, V Kaza, J Chen, T J Standiford and V G Keshamouni Oncogene 2016 35: 1888-1898; advance online publication, July 6, 2015; 10.1038/onc.2015.258 Abstract | Full Text Integrin α11β1 regulates cancer stromal stiffness and promotes tumorigenicity and metastasis in non-small cell lung cancer OPEN R Navab, D Strumpf, C To, E Pasko, K S Kim, C J Park, J Hai, J Liu, J Jonkman, M Barczyk, B Bandarchi, Y H Wang, K Venkat, E Ibrahimov, N-A Pham, C Ng, N Radulovich, C-Q Zhu, M Pintilie, D Wang, A Lu, I Jurisica, G C Walker, D Gullberg and M-S Tsao Oncogene 2016 35: 1899-1908; advance online publication, July 6, 2015; 10.1038/onc.2015.254 Abstract | Full Text TSH overcomes BrafV600E-induced senescence to promote tumor progression via downregulation of p53 expression in papillary thyroid cancer M Zou, E Y Baitei, R A Al-Rijjal, R S Parhar, F A Al-Mohanna, S Kimura, C Pritchard, H A Binessa, A S Alzahrani, H H Al-Khalaf, A Hawwari, M Akhtar, A M Assiri, B F Meyer and Y Shi Oncogene 2016 35: 1909-1918; advance online publication, October 19, 2015; 10.1038/onc.2015.253 Abstract | Full Text Structural basis of how stress-induced MDMX phosphorylation activates p53 X Chen, N Gohain, C Zhan, W-Y Lu, M Pazgier and W Lu Oncogene 2016 35: 1919-1925; advance online publication, July 6, 2015; 10.1038/onc.2015.255 Abstract | Full Text Focal adhesion kinase-promoted tumor glucose metabolism is associated with a shift of mitochondrial respiration to glycolysis J Zhang, Q Gao, Y Zhou, U Dier, N Hempel and S N Hochwald Oncogene 2016 35: 1926-1942; advance online publication, June 29, 2015; 10.1038/onc.2015.256 Abstract | Full Text PAK5-mediated E47 phosphorylation promotes epithelial–mesenchymal transition and metastasis of colon cancer G Zhu, X Li, B Guo, Q Ke, M Dong and F Li Oncogene 2016 35: 1943-1954; advance online publication, July 27, 2015; 10.1038/onc.2015.259 Abstract | Full Text RING finger protein 31 promotes p53 degradation in breast cancer cells OPEN J Zhu, C Zhao, T Zhuang, P Jonsson, I Sinha, C Williams, S Strömblad and K Dahlman-Wright Oncogene 2016 35: 1955-1964; advance online publication, July 6, 2015; 10.1038/onc.2015.260 Abstract | Full Text The oncofusion protein FUS–ERG targets key hematopoietic regulators and modulates the all-trans retinoic acid signaling pathway in t(16;21) acute myeloid leukemia OPEN A M Sotoca, K H M Prange, B Reijnders, A Mandoli, L N Nguyen, H G Stunnenberg and J H A Martens Oncogene 2016 35: 1965-1976; advance online publication, July 6, 2015; 10.1038/onc.2015.261 Abstract | Full Text The thyroid hormone-αvβ3 integrin axis in ovarian cancer: regulation of gene transcription and MAPK-dependent proliferation E Shinderman-Maman, K Cohen, C Weingarten, D Nabriski, O Twito, L Baraf, A Hercbergs, P J Davis, H Werner, M Ellis and O Ashur-Fabian Oncogene 2016 35: 1977-1987; advance online publication, July 13, 2015; 10.1038/onc.2015.262 Abstract | Full Text Syk-mediated tyrosine phosphorylation of mule promotes TNF-induced JNK activation and cell death C K Lee, Y Yang, C Chen and J Liu Oncogene 2016 35: 1988-1995; advance online publication, July 27, 2015; 10.1038/onc.2015.275 Abstract | Full Text Short Communications Top Minimal asbestos exposure in germline BAP1 heterozygous mice is associated with deregulated inflammatory response and increased risk of mesothelioma A Napolitano, L Pellegrini, A Dey, D Larson, M Tanji, E G Flores, B Kendrick, D Lapid, A Powers, S Kanodia, S Pastorino, H I Pass, V Dixit, H Yang and M Carbone Oncogene 2016 35: 1996-2002; advance online publication, June 29, 2015; 10.1038/onc.2015.243 Abstract | Full Text Opposing effects of pericentrin and microcephalin on the pericentriolar material regulate CHK1 activation in the DNA damage response A K Antonczak, L I Mullee, Y Wang, D Comartin, T Inoue, L Pelletier and C G Morrison Oncogene 2016 35: 2003-2010; advance online publication, July 13, 2015; 10.1038/onc.2015.257 Abstract | Full Text Advertisement Oncogenesis is an online-only, open access journal exploring the molecular basis of cancer and related phenomena. The journal seeks to promote diverse and integrated areas of molecular biology, cell biology, oncology, and genetics. The journal has an Impact Factor of 3.952. Explore the benefits of submitting your next research article. Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Oncogene. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at Brunel Road, Houndmills, Basingstoke, Hampshire RG21 6XS. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.